HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced plans to participate in the upcoming Piper Sandler 38th Annual Healthcare Conference in New York, NY. Pulse Biosciences’ Management is scheduled to present on Thursday, December 3, at 8:50 am ET. A live and recorded webcast of the presentation will be available on the “Events Ca

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.